CERUBIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Cerubidine patents expire, and what generic alternatives are available?
Cerubidine is a drug marketed by Hikma, Sanofi Aventis Us, and Wyeth Ayerst. and is included in three NDAs.
The generic ingredient in CERUBIDINE is daunorubicin hydrochloride. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the daunorubicin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cerubidine
A generic version of CERUBIDINE was approved as daunorubicin hydrochloride by HIKMA on January 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CERUBIDINE?
- What are the global sales for CERUBIDINE?
- What is Average Wholesale Price for CERUBIDINE?
Summary for CERUBIDINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 70 |
| Patent Applications: | 4,483 |
| DailyMed Link: | CERUBIDINE at DailyMed |
Recent Clinical Trials for CERUBIDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| City of Hope Medical Center | Phase 1 |
| PrECOG, LLC. | Phase 2 |
| Astellas Pharma Inc | Phase 2 |
US Patents and Regulatory Information for CERUBIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CERUBIDINE | daunorubicin hydrochloride | INJECTABLE;INJECTION | 064103-001 | Feb 3, 1995 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sanofi Aventis Us | CERUBIDINE | daunorubicin hydrochloride | INJECTABLE;INJECTION | 061876-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | CERUBIDINE | daunorubicin hydrochloride | INJECTABLE;INJECTION | 050484-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
